Plexus Corp. (PLXS)

We are raising our F2026/F2027E (Sept) EPS from $8.05/$9.50 to $8.70/$10.30 on Plexus (PLXS; $260.77; E/W) after the company posted a healthy FQ3 (Jun) “beat and raise” last week where management also signaled confidence in…

We are raising our F2026/2027E (Sept) EPS on Plexus (PLXS; $250.08; E/W) from $7.70/$8.70 to $8.05/$9.50, which equates to average EPS growth of 13% across these two fiscal years, albeit now positioned to generally accelerate…

We are raising our F2026/F2027E (Sep) EPS for Plexus (PLXS; $197.60; E/W) from $7.45/$8.45 to $7.70/$8.70 after the company produced basically as expected FQ1 (Dec) EPS with FQ2E (Mar) guidance that was comfortably ahead of…

Plexus (PLXS; $180.85; E/W) reported FQ1 (Dec) non-GAAP EPS of $1.78, which was ahead of our $1.75 and the Street’s $1.76, albeit on some lower than expected sales ($1,070mm vs. our $1,075mm and the Street’s…

On Tuesday (11/4), we hosted virtual investor meetings for the management team of Plexus (PLXS; $143.32; E/W), which included participation from CEO Todd Kelsey, CFO Patrick Jermain as well as Mike Running, Regional President, Americas,…

We adjust F2026E (Sept) EPS from $7.40 to $7.45 for Plexus (PLXS; $149.86; E/W) after it produced FQ4 (Sept) results that basically lined up with our expectations, albeit with some puts and takes, and excluding…

Plexus (PLXS; $146.10; E/W) reported FQ4 (Sep) non-GAAP EPS of $2.14, which was well ahead of our $1.90 and the Street’s $1.87 due basically to non-operating items as described below (e.g., tax benefits). At the…

We think the general demand backdrop across Plexus’ (PLXS; $150.25; E/W) core markets should enable the company to produce FQ4 (Sept) results and guidance, scheduled for next Wednesday (10/22 after market), that at least live…

We adjust our F2025/F2026E (Sept) EPS for Plexus (PLXS; $118.29; E/W) from $7.05/$7.70 to $7.20/$7.40 after it produced FQ3 (Jun) EPS upside, albeit on as expected operating profits, but with FQ4E (Sept) guidance that was…

Plexus (PLXS; $133.83; E/W) reported FQ3 (Jun) non-GAAP EPS of $1.90, which was ahead of our $1.73 and the Street’s $1.71, albeit on some lower-than-expected sales ($1,018mm vs. our $1,025mm and the Street’s $1,021mm) and…

We do not expect meaningful changes to our F2025/F2026E (Sep) EPS for Plexus (PLXS; $133.11; E/W) after its FQ3E (Jun) results and guidance on Wednesday, July 23rd (after market). To that end, we model F2025/F2026E…

Last night, Plexus (PLXS; $132.09; E/W) announced that its Board authorized a $100mm increase to its share repurchase program. By comparison, PLXS’ market cap is $3.7B and the company disclosed that it had $18mm remaining…

We bump up our F2025/F2026E (Sept) EPS for Plexus (PLXS; $125.35; E/W) from $6.90/$7.55 to $7.05/$7.70 after the company produced some FQ2 (Mar) EPS upside, led by healthier than expected operating margins, and FQ3E (Jun)…

Plexus (PLXS; $127.17; E/W) reported FQ2 (Mar) non-GAAP EPS of $1.66, comfortably beating our consensus matching $1.54, on sales of $980mm, which was basically in line with the Street’s $981mm and slightly below our more…

We assume Plexus’ (PLXS; $121.28; E/W) relative mix of served market exposure and global footprint proves new tariffs to be less of an issue for the company relative to others we follow in the supply…